Both antibodies have epitopes outside known phosphorylation sites in PHFs and acetylated Lys174, Lys274 and Lys280 that have been described in the tau deposits of AD, FTDP-17, and PiD patients [1, 2, 8]. This evidence concerns the gene MAPT and Alzheimer disease.